DJIA 17,598.20 -91.66 -0.52%
NASDAQ 5,115.38 -12.90 -0.25%
S&P 500 2,098.04 -5.80 -0.28%
market minute promo

70.06 1.04 (1.51%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

TEVA $70.06 1.51%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $69.06
Previous Close $69.02
Daily Range $68.76 - $70.12
52-Week Range $47.36 - $72.31
Market Cap $58.8B
P/E Ratio 46.32
Dividend (Yield) $1.36 (1.7%)
Ex-Dividend Date
Dividend Pay Date
08/18/15
09/03/15
Volume 5,264,045
Average Daily Volume 5,675,390
Current FY EPS $5.24

Sector

Healthcare

Industry

Drug Makers

Teva Pharmaceutical Industries (TEVA) Description

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories. Website: http://www.tevapharm.com/

News & Commentary

The Most Important Number in Gilead Sciences' Earnings Report

In this episode, we dig into Teva Pharmaceuticals' recent M&A and debate the single most important number reported in Gilead Sciences' second-quarter earnings results.

Teva's Deal-Making Spurs Inflows To Israel ETFs

Calls Of Note: The Street's Research Moving Stocks This Monday

Will Teva (TEVA) Stock be Helped by New Financing Commitment?

Teva Proves Its Decade-Hold Status With Massive Funding

Israel ETFs Surge on Teva Megamerger Deal (revised) - ETF News And Commentary

Teva's Q2 Earnings & Revenues Beat Expectations, View Up - Analyst Blog

Teva Pharmaceutical Industries Ltd. Beats The Street in the Second Quarter: What's Next?

Teva Pharmaceutical Industries Ltd. handily beat consensus today. Here's what you need to know right now.

The Tale of Two Teva Pharmaceuticals

Revenue down, earnings up. At least it wasn't the other way around.

Teva Pharmaceutical (TEVA) Earnings Report: Q2 2015 Conference Call Transcript

See More TEVA News...

TEVA's Top Competitors

TEVA $70.06 (1.51%)
Current stock: TEVA
JNJ $100.02 (-0.19%)
Current stock: JNJ
NVS $104.36 (0.59%)
Current stock: NVS
PFE $36.15 (0.25%)
Current stock: PFE